Collaboration with the International Vaccine Institute (IVI: 2025-Present)
Partnering with IVI to prevent neonatal sepsis through the development of a multivalent Klebsiella pneumoniae vaccine.
Status:
Ongoing
Objective
In partnership with the International Vaccine Institute, this project focuses on preventing neonatal sepsis caused by Klebsiella pneumoniae. The project also includes the development and demonstration of a multivalent vaccine targeting key bacterial surface antigens, capsular (K) and O-specific polysaccharides, to support vaccine development.
Gallery
No images found for this project yet.
You may also be interested in
Drug Targets in Klebsiella
Identification and Validation of Drug Targets in Klebsiella Species.
GPAP Project
An AI-powered, open-access system for analyzing, storing, and sharing pathogen genomic data.
Laboratory-Based Surveillance of MDR Organisms
Laboratory-Based Surveillance of Multidrug-Resistant Organisms.
ASSARM-PHI Project
Air Sampling Surveillance for AMR Monitoring and Pathogens of Public Health Interest.
Neonatal Infections Genomics
Whole genome sequencing of K. pneumoniae and E. coli from neonatal infections in Ghana.
GHRU Project
GHRU Prospective Structured Survey on CRKP, Escherichia coli, and Acinetobacter.
SEQAFRICA Project
Whole Genome Sequencing of Antimicrobial-Resistant Bacteria in Africa SEQAFRICA Project.
ESKAPE Project
Antimicrobial Resistance and Molecular Epidemiology of ESKAPE Pathogens Associated with Infections.
SSI Project
Investigating the prevalence of MRSA and ESBL-producing bacteria in SSI to guide antimicrobial stewardship.
MDR Pathogens in Hospital Wastewater and Environmental Surfaces
Multidrug-resistant pathogens in hospital wastewater and environmental surfaces at 37 Military Hospital.
Surveillance, Characterization, And AMR of Travelers’ Diarrhea Pathogens in Ghana
Surveillance, Characterization, And Antimicrobial Resistance of Travelers’ Diarrhea Pathogens.